行情

BSX

BSX

波士顿科学
NYSE

实时行情|Nasdaq Last Sale

43.36
-0.28
-0.64%
盘后: 43.09 -0.27 -0.62% 16:11 09/21 EDT
开盘
44.02
昨收
43.64
最高
44.36
最低
43.34
成交量
623.98万
成交额
--
52周最高
46.29
52周最低
32.99
市值
617.10亿
市盈率(TTM)
117.84
分时
5日
1月
3月
1年
5年
BRIEF-Boston Scientific Agrees To Acquire Devoro Medical
reuters.com · 8小时前
波士顿科学公布了肿瘤靶向微珠的结直肠癌生存数据
Benzinga · 1天前
最新数据表明,波士顿科学 TheraSphere™ Y-90 玻璃微球治疗后转移性结直肠癌患者的无进展生存期有所改善
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced the EPOCH clinical trial of the TheraSphere™ Glass Microspheres (TheraSphere treatment) successfully met both primary endpoints, including progression-free survival (PFS) and hepatic prog...
PR Newswire - PRF · 1天前
2029 年泌尿外科激光市场新兴受众、细分市场、行业销售、利润和区域分析
Research Nester released a report titled which delivers detailed overview of the Urology Laser Market in terms of market segmentation by laser type, application and region.
AmericaNewsHour · 1天前
波士顿科学公司对 TheraSphere Y-90 玻璃微球的试验达到主要终点
MT Newswires · 1天前
波士顿科学的高级副总裁和人力资源部以 149.05 万美元的价格出售
Wendy Carruthers, SVP And Human Resources at Boston Scientific (NYSE:BSX), made a large insider sell on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Ca...
Benzinga · 5天前
9 月 15 日的“快钱半场报告”精选
On CNBC's "Fast Money Halftime Report," Karen Firestone said Charles Schwab (NYSE: SCHW) has a lot of new young traders who have larger accounts than Robinhood Mar
Benzinga · 6天前
良性前列腺增生治疗市场:全球行业规模、增长率、新兴趋势、区域分析和研究报告以及到 2029 年的预测
Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2029"which delivers detailed overview of the benign prostatic hyperplasia treatment market in terms of market segmentation by treatment type, application and region.
AmericaNewsHour · 6天前
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解BSX最新的财务预测,通过BSX每股收益,每股净资产,每股现金流等数据分析波士顿科学近期的经营情况,然后做出明智的投资选择。
分析师评级

32位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测BSX价格均价为51.08,最高价位57.00,最低价为41.00。
EPS
机构持股
总机构数: 1,151
机构持股: 14.38亿
持股比例: 100.98%
总股本: 14.24亿
类型机构数股数
增持
291
6,179.36万
建仓
99
1,381.21万
减持
304
5,526.73万
平仓
56
1,141.74万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
+0.43%
医疗设备和用品
+0.23%
高管信息
Chairman/President/Chief Executive Officer/Director
Michael Mahoney
Chief Financial Officer/Executive Vice President
Daniel Brennan
Executive Vice President
Arthur Butcher
Executive Vice President
Joseph Fitzgerald
Executive Vice President
Edward Mackey
Executive Vice President
Ian Meredith
Executive Vice President
Jeffrey Mirviss
Executive Vice President
David Pierce
Executive Vice President
Eric Thepaut
Senior Vice President/Chief Information Officer
Jodi Eddy
Senior Vice President/General Counsel/Secretary
Desiree Rallsmorrison
Senior Vice President/Director of Human Resources
Wendy Carruthers
Senior Vice President
Maulik Nanavaty
Senior Vice President
Scott Olson
Senior Vice President
Meghan Scanlon
Senior Vice President
John Sorenson
Lead Director/Independent Director
Edward Ludwig
Director
David Wichmann
Independent Director
Nelda Connors
Independent Director
Charles Dockendorff
Independent Director
Yoshiaki Fujimori
Independent Director
Donna James
Independent Director
David Roux
Independent Director
John Sununu
Independent Director
Ellen Zane
暂无数据
BSX 简况
波士顿科学公司是一家医疗器械的开发商、制造商和营销商,这些器械用于一系列介入医学专业。该公司通过介入心脏病学、外周干预、心律管理、电生理学、内窥镜检查、泌尿科和盆腔健康、神经调节和专业制药等业务提供产品。该公司运营三个分部:医学外科分部、心律和神经分部和心血管分部。医学外科分部由内窥镜检查、泌尿外科和盆腔健康业务组成。心律分部包括心律管理、电生理学和神经调节业务。心血管分部包括介入心脏病学和外周介入业务。其产品包括球囊导管、旋磨系统、导丝、引导导管、栓塞保护装置和用于经皮冠状动脉血管成形术 (PTCA) 手术的诊断导管。

微牛提供Boston Scientific Corporation(NYSE-BSX)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的BSX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易BSX股票基本功能。